help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ortiz, M. A.
Right arrow Articles by Maki, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ortiz, M. A.
Right arrow Articles by Maki, R.

Molecular Endocrinology, Vol 9, 1679-1691, Copyright © 1995 by Endocrine Society


ARTICLES

TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals

MA Ortiz, FJ Piedrafita, M Pfahl and R Maki
La Jolla Cancer Research Foundation, California 92037, USA.

Vitamin A and other fat-soluble hormones and vitamins have important roles as modulators of essential biological processes such as homeostasis, development, differentiation, and oncogenesis and also as regulators of the immune system. The active form of vitamin A, retinoic acid, as well as vitamin D3 and thyroid hormones exert their actions by binding to specific nuclear receptors that represent one subfamily of the steroid/thyroid hormone receptor superfamily. To identify new members of the retinoid/thyroid hormone receptor subfamily that could play a role in the immune system, a screening of a T cell cDNA library was performed using a retinoid X receptor probe. A clone was isolated encoding a novel nuclear receptor expressed mainly in the thymus and T cell lines. This new receptor, TOR (thymus orphan receptor), is most closely related in both its DNA-binding domain and ligand-binding domain, 90% and 53%, respectively, to ROR alpha/RZR alpha and clusters with these two receptors and RZR beta in a phylogenetic tree, when both the DNA-binding domain and the ligand-binding domain sequences of nuclear receptors are compared. Thus, TOR is part of a subgroup of receptors, one of which has recently been reported to be activated by melatonin. TOR binds specifically to a direct repeat of the half-site sequence 5'-AGGTCA-3' with a four- or five-nucleotide spacer, DNA sequences that also serve as binding sites for thyroid hormone (TR), and retinoic acid receptors (RAR). In transient transfection experiments TOR does not activate a reporter gene carrying these sequences in the absence or the presence of any known nuclear receptor ligands. TOR, however, is able to repress TR and RAR activity on DR-4- TREs or DR-5-RAREs, respectively. Therefore, our data suggest that TOR, similar to COUP-TF, can negatively regulate retinoic acid and thyroid hormone signals. However, the response elements recognized by TOR and COUP-TF differ as do the expression patterns of these receptors. Thus, one important role of TOR could be to modulate retinoid and thyroid hormone signals in the thymus.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
S. Raichur, P. Lau, B. Staels, and G. E O Muscat
Retinoid-related orphan receptor {gamma} regulates several genes that control metabolism in skeletal muscle cells: links to modulation of reactive oxygen species production
J. Mol. Endocrinol., July 1, 2007; 39(1): 29 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Tilley, M. Jaradat, C. Stapleton, D. Dixon, X. Hua, C. J. Erikson, J. G. McCaskill, K. D. Chason, G. Liao, L. Jania, et al.
Retinoid-Related Orphan Receptor {gamma} Controls Immunoglobulin Production and Th1/Th2 Cytokine Balance in the Adaptive Immune Response to Allergen
J. Immunol., March 1, 2007; 178(5): 3208 - 3218.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al.
International Union of Pharmacology. LXVI. Orphan Nuclear Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
F. Guillaumond, H. Dardente, V. Giguere, and N. Cermakian
Differential Control of Bmal1 Circadian Transcription by REV-ERB and ROR Nuclear Receptors
J Biol Rhythms, October 1, 2005; 20(5): 391 - 403.
[Abstract] [PDF]


Home page
J. Immunol.Home page
H. Xie, M. S. Sadim, and Z. Sun
ROR{gamma}t Recruits Steroid Receptor Coactivators to Ensure Thymocyte Survival
J. Immunol., September 15, 2005; 175(6): 3800 - 3809.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Lau, S. J. Nixon, R. G. Parton, and G. E. O. Muscat
ROR{alpha} Regulates the Expression of Genes Involved in Lipid Homeostasis in Skeletal Muscle Cells: CAVEOLIN-3 AND CPT-1 ARE DIRECT TARGETS OF ROR
J. Biol. Chem., August 27, 2004; 279(35): 36828 - 36840.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. R. Broussard, M. M. Lozano, and J. P. Dudley
Ror{gamma} (Rorc) Is a Common Integration Site in Type B Leukemogenic Virus-Induced T-Cell Lymphomas
J. Virol., May 1, 2004; 78(9): 4943 - 4946.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y.-W. He
Orphan nuclear receptors in T lymphocyte development
J. Leukoc. Biol., September 1, 2002; 72(3): 440 - 446.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Ueda, S. Kurebayashi, M. Sakaue, M. Backlund, B. Koller, and A. M. Jetten
High Incidence of T-Cell Lymphomas in Mice Deficient in the Retinoid-related Orphan Receptor ROR{gamma}
Cancer Res., February 1, 2002; 62(3): 901 - 909.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Kurebayashi, E. Ueda, M. Sakaue, D. D. Patel, A. Medvedev, F. Zhang, and A. M. Jetten
Retinoid-related orphan receptor gamma (RORgamma ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis
PNAS, August 29, 2000; 97(18): 10132 - 10137.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Z. Sun, D. Unutmaz, Y.-R. Zou, M. J. Sunshine, A. Pierani, S. Brenner-Morton, R. E. Mebius, and D. R. Littman
Requirement for RORgamma in Thymocyte Survival and Lymphoid Organ Development
Science, June 30, 2000; 288(5475): 2369 - 2373.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
Y.-W. He, C. Beers, M. L. Deftos, E. W. Ojala, K. A. Forbush, and M. J. Bevan
Down-Regulation of the Orphan Nuclear Receptor ROR{gamma}t Is Essential for T Lymphocyte Maturation
J. Immunol., June 1, 2000; 164(11): 5668 - 5674.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. Giguère
Orphan Nuclear Receptors: From Gene to Function
Endocr. Rev., October 1, 1999; 20(5): 689 - 725.
[Abstract] [Full Text]


Home page
Cold Spring Harb Symp Quant BiolHome page
D.R. LITTMAN, Z. SUN, D. UNUTMAZ, M.J. SUNSHINE, H.T. PETRIE, and Y.-R. ZOU
Role of the Nuclear Hormone Receptor ROR{gamma} in Transcriptional Regulation, Thymocyte Survival, and Lymphoid Organogenesis
Cold Spring Harb Symp Quant Biol, January 1, 1999; 64(0): 373 - 382.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
G. W. Anderson, R. J. Larson, D. R. Oas, C. R. Sandhofer, H. L. Schwartz, C. N. Mariash, and J. H. Oppenheimer
Chicken Ovalbumin Upstream Promoter-Transcription Factor (COUP-TF) Modulates Expression of the Purkinje Cell Protein-2 Gene. A POTENTIAL ROLE FOR COUP-TF IN REPRESSING PREMATURE THYROID HORMONE ACTION IN THE DEVELOPING BRAIN
J. Biol. Chem., June 26, 1998; 273(26): 16391 - 16399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Missbach, B. Jagher, I. Sigg, S. Nayeri, C. Carlberg, and I. Wiesenberg
Thiazolidine Diones, Specific Ligands of the Nuclear Receptor Retinoid Z Receptor/Retinoid Acid Receptor-related Orphan Receptor alpha with Potent Antiarthritic Activity
J. Biol. Chem., June 7, 1996; 271(23): 13515 - 13522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society